Cidara Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cidara Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Cidara Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.45 USD/shares, a 21.3% decline year-over-year.
  • Cidara Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -20.5 USD/shares, a 348% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.26 USD/shares, a 45.8% increase from 2022.
  • Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.48 USD/shares, a 40.7% increase from 2021.
  • Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.81 USD/shares, a 55% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 +$0.22 +45.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-22
2022 $0 +$0.33 +40.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-22
2021 -$1 +$0.99 +55% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$2 $0 -31.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$1 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.